Elikya Therapeutics
PrivateCompany Overview
Elikya Therapeutics is a biotechnology company that develops next-generation antibody-drug conjugates (ADCs) with first-in-class toxic payloads for oncology treatments.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Elikya Therapeutics Comparables
Compare Elikya Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Seekyo | 87% | |
| Eli Lilly and Company | 82% | |
| Phrontline Biopharma | 81% |
Elikya Therapeutics Funding Rounds
Historical fundraising activity
Elikya Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Landmark BioVentures AG | Seed |
| SEMIA | Seed |
| SATT Paris-Saclay | Seed |
| Bpifrance | Grant |
Elikya Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Elikya Therapeutics's valuation, stock price, and market status.
Is Elikya Therapeutics a public or private company?
Elikya Therapeutics is a private company.
What is the current stock price of Elikya Therapeutics?
Elikya Therapeutics is a private company with no public stock price. Caplight tracks Elikya Therapeutics's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Elikya Therapeutics worth (valuation)?
Valuation information for Elikya Therapeutics is not publicly available.
Can I buy Elikya Therapeutics stock?
Elikya Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Elikya Therapeutics's last funding round?
Funding round information for Elikya Therapeutics is not publicly available.
Who are the main investors in Elikya Therapeutics?
Key investors in Elikya Therapeutics include Landmark BioVentures AG, SEMIA, SATT Paris-Saclay, Bpifrance.
Will Elikya Therapeutics IPO soon?
No public IPO plans have been announced for Elikya Therapeutics.
How can I track Elikya Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Elikya Therapeutics's secondary market activity and sign up for updates.